Carnegie Investment Bank AB (publ) ("Carnegie"), Citigroup Global Markets Europe AG ("Citigroup") and Nordea Bank Abp, filial i Sverige ("Nordea", and together with Carnegie and Citigroup, the "Joint Global Coordinators") have today notified Asker Healthcare Group AB (publ) ("Asker" or the "Company"), Nalka Invest AB¹ ("Nalka") and Ilmarinen Mutual Pension Insurance Company ("Ilmarinen") that the overallotment option has been exercised in full. Nordea, as stabilisation manager on behalf of the Joint Global Coordinators, has notified that the stabilisation period has now ended in advance. No price stabilisation measures have been or will be carried out.

In connection with the offering and listing of Asker's shares on Nasdaq Stockholm on 27 March 2025 (the "Offering"), the shareholders Nalka and Ilmarinen issued an option entitling the Joint Global Coordinators to request that up to an additional 19,042,965 shares, corresponding to 15 percent of the total number of shares in the Offering, are acquired to cover any overallotment in the Offering.

No price stabilisation measures have been carried out since the listing on 27 March 2025, and in light of the Company's share price performance, the Joint Global Coordinators have decided to fully exercise the overallotment option and Nordea, as stabilisation manager on behalf of the Joint Global Coordinators, has notified that the stabilisation period has now ended in advance.

For further information, please contact:

Emma Rheborg, Head of Communications
Tel: +46733136217
E-mail: emma.rheborg@asker.com

The information was submitted for publication, through the agency of the contact persons set out above, at 19:15 CEST on 7 April 2025.

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group - driving progress in the healthcare sector. The group has more than 4,000 employees in 17 countries.

IMPORTANT INFORMATION

This announcement is not, and does not form part of, an offer to sell or buy any securities. This announcement is not being made, and may not be distributed in or sent to, the United States of America, Australia, Canada, or Japan, or any other jurisdiction where such distribution would be unlawful or require registration or any other measures.

The offering of the securities referred to in this announcement has been made by means of a prospectus (the "Prospectus"). This announcement is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the "Prospectus Regulation"). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned Prospectus.

This announcement and the information contained herein are not for distribution in or into the United States of America. This announcement does not constitute an offer to sell securities in the United States of America. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States of America without registration or an exemption from registration under the Securities Act and in accordance with applicable securities laws of the states of the United States of America. No public offering of securities is being made in the United States of America.

This announcement is only addressed to and are only directed at persons in any member state of the EEA, with the exception of Sweden, Denmark, Norway, Finland and the United Kingdom (each a "Relevant State") who are "Qualified Investors" within the meaning of Article 2(e) of the Prospectus Regulation or the Prospectus Regulation made part of United Kingdom law by the European Union (Withdrawal) Act 2018, as applicable.

This announcement does not constitute an offer of securities to the public in the United Kingdom. No prospectus has been or will be registered in the United Kingdom in respect of the securities. In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, qualified investors (as defined in the Prospectus Regulation as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018) and who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "Relevant Persons"). This announcement must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this announcement must satisfy themselves that it is lawful to do so.

This announcement may contain certain forward-looking statements. Such statements include statements regarding the Company's business strategy, financial condition, profitability, market data and other statements that are not historical facts and include expressions such as "believes", "considers", "estimates", "expects", "anticipates", "assumes", "predicts", "intends", "may", "continues", "should", "aims", "forecasts", "guides" or similar expressions. The forward-looking statements in this announcement are based on various estimates and assumptions, many of which are based on additional assumptions. Although the Company believes that these assumptions were reasonable when made, such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that are difficult or impossible to predict and are beyond the Company's control. Such risks, uncertainties and material factors could cause actual results to differ materially from those expressed or implied in this announcement by the forward-looking statements. The information, beliefs and forward-looking statements contained in this announcement speak only as of the date of this announcement and are subject to change without notice.

----------------------------------------------------